ORGO (Organogenesis Holdings) Days Payable : 77.70 (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Organogenesis Holdings Days Payable?

Organogenesis Holdings's average Accounts Payable for the three months ended in Dec. 2024 was $26.4 Mil. Organogenesis Holdings's Cost of Goods Sold for the three months ended in Dec. 2024 was $31.1 Mil. Hence, Organogenesis Holdings's Days Payable for the three months ended in Dec. 2024 was 77.70.

The historical rank and industry rank for Organogenesis Holdings's Days Payable or its related term are showing as below:

ORGO' s Days Payable Range Over the Past 10 Years
Min: 84.25 Med: 107.62 Max: 114.27
Current: 85.92

During the past 10 years, Organogenesis Holdings's highest Days Payable was 114.27. The lowest was 84.25. And the median was 107.62.

ORGO's Days Payable is ranked better than
50% of 944 companies
in the Drug Manufacturers industry
Industry Median: 85.915 vs ORGO: 85.92

Organogenesis Holdings's Days Payable declined from Dec. 2023 (94.49) to Dec. 2024 (77.70). It may suggest that Organogenesis Holdings accelerated paying its suppliers.

Organogenesis Holdings Days Payable Historical Data

The historical data trend for Organogenesis Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organogenesis Holdings Days Payable Chart

Organogenesis Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

108.20

84.25

107.17

108.07

94.03

Organogenesis Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															94.49	85.78	82.22	90.86	77.70

Competitive Comparison of Organogenesis Holdings's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Organogenesis Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organogenesis Holdings's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organogenesis Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Organogenesis Holdings's Days Payable falls into.

Save Embed

;

Save Embed

;

Organogenesis Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Organogenesis Holdings's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (30.724	+	28.911)	/	2 )	/	115.741	*	365
=	29.8175					/	115.741	*	365
=	94.03

Organogenesis Holdings's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (23.971	+	28.911)	/	2 )	/	31.051	*	365 / 4
=	26.441					/	31.051	*	365 / 4
=	77.70

Organogenesis Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Organogenesis Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Organogenesis Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organogenesis Holdings Inc (NAS:ORGO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

85 Dan Road, Canton, MA, USA, 02021

Website

https://www.organogenesis.com

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Executives

Michael Joseph Driscoll	director	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021
Gary S. Gillheeney	director, officer: President and CEO	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021
Albert Erani	10 percent owner	150 DAN ROAD, 150 DAN ROAD, CANTON MA 01002
Michael W Katz	10 percent owner
Arthur S Leibowitz	director	139 SOUNDVIEW DRIVE, PORT WASHINGTON NY 11050
Gilberto Quintero	director	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021
Michele Ilene Korfin	director	17 STATE STREET, 7TH FLOOR, NEW YORK NY 10004
Antonio S. Montecalvo	officer: VP Health Policy & Contracting	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021
Jon L Giacomin	director	7000 CARDINAL PLACE, DUBLIN OH 43017
David Francisco	officer: Chief Financial Officer	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021
Red Holdings, Llc	10 percent owner	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021
Prathyusha Duraibabu	director	C/O SANGAMO THERAPEUTICS, INC., 501 CANAL BLVD., RICHMOND CA 94804
Glenn H Nussdorf	director, 10 percent owner
Alan A. Ades	director, 10 percent owner	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021
Gn 2016 Organo 10-year Grat U/a/d September 30, 2016	10 percent owner	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021